First Trust Advisors LP Sage Therapeutics, Inc. Transaction History

First Trust Advisors LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $613,770 - $1.79 Million	36,643 Added 96.83%	74,485 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $1.22 Million - $1.79 Million	30,064 Added 386.53%	37,842 $1.78 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $1.42 Million - $1.77 Million	-37,993 Reduced 83.01%	7,778 $326,000
Q4 2022 Feb 09, 2023	BUY	$32.2 - $43.61 $1.19 Million - $1.61 Million	36,917 Added 416.95%	45,771 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $285,807 - $383,112	8,854 New	8,854 $347,000
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $23.2 Million - $32.1 Million	-844,652 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.02 Million - $1.52 Million	33,218 Added 4.09%	844,652 $28 Million
Q4 2021 Feb 08, 2022	BUY	$37.06 - $47.11 $8.24 Million - $10.5 Million	222,395 Added 37.76%	811,434 $34.5 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $7.18 Million - $10.2 Million	178,286 Added 43.4%	589,039 $26.1 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $8.83 Million - $12.8 Million	160,865 Added 64.37%	410,753 $23.3 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $5.84 Million - $8.01 Million	82,731 Added 49.49%	249,888 $18.7 Million
Q4 2020 Feb 02, 2021	BUY	$58.41 - $89.06 $9.76 Million - $14.9 Million	167,157 New	167,157 $14.5 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.